WICHITA, Kan. (KSNW) — An update on a story we brought you in March.
Natalie Graves has Crohn’s disease, a chronic inflammatory bowel disease. She was on a medical infusion treatment called Remicade. Instead, Blue Cross and Blue Shield of Kansas offered her two other options, Inflectra and Avsola. When she switched, she said her disease’s symptoms flared up again.
“I had a colonoscopy on Thursday to assess the overall damage to what’s going on, and they found that I have some erosions and ulcers caused by that biosimilar medication not being able to manage and control my Crohn’s,” Graves said…